Lamb G C, Roush G
Department of Internal Medicine, Northeastern Ohio Universities College of Medicine, Canton.
J Gen Intern Med. 1988 Jul-Aug;3(4):326-30. doi: 10.1007/BF02595789.
Alkaline phosphatase isoenzyme determination (APID) is in common use despite evidence suggesting that the results correlate poorly with actual sites of disease. To assess the predictive value of this test in clinical practice, 99 APIDs performed on 94 patients were identified and the patients' charts were reviewed. Results of APID were compared with actual patient diagnoses as determined by other means. The liver isoenzyme fraction was not very accurate in predicting the presence of liver disease (positive predictive value 68%). In contrast, the bone isoenzyme fraction was insensitive (56%) but a positive test predicted bone disease well (positive predictive value 93%). The association of elevated transaminases with elevated alkaline phosphatase on a chemistry profile was as useful as APID in identifying liver disease, suggesting that APID should not be done in this setting. Using this information, APID can be helpful in the assessment of an ill patient with an elevated alkaline phosphatase.
尽管有证据表明碱性磷酸酶同工酶测定(APID)结果与疾病实际部位的相关性较差,但该方法仍被广泛使用。为评估此检测在临床实践中的预测价值,我们对94例患者进行的99次APID检测进行了鉴定,并查阅了患者病历。将APID结果与通过其他方法确定的患者实际诊断结果进行比较。肝脏同工酶部分在预测肝病存在方面不太准确(阳性预测值为68%)。相比之下,骨同工酶部分不敏感(56%),但阳性检测对骨病的预测效果较好(阳性预测值为93%)。在化学检查中,转氨酶升高与碱性磷酸酶升高的关联在识别肝病方面与APID同样有用,这表明在此情况下不应进行APID检测。利用这些信息,APID有助于评估碱性磷酸酶升高的患病患者。